Forskolin Regulates the Expression of CTGF in Mouse Cardiac Fibroblasts by Activating the cAMP Signaling Pathway

刘波,黄晓帆,李冬寒,王生伟,杜心灵
DOI: https://doi.org/10.3870/j.issn.1672-0741.2015.01.001
2015-01-01
Abstract:Objective To examine the effects of the increased levels of cyclic adenosine monophosphate (cAMP)on the ex‐pression of connective tissue growth factor(CTGF)in mouse cardiac fibroblasts(MCFs)and the related signal transduction path‐way.Methods MCFs from the hearts of 1‐week‐old C57BL mice were isolated and primarily cultured.The expression levels of CTGF ,protein kinase A(PKA) ,p44/42 mitogen activated protein kinase(MAPK)and phospho‐p44/42 MAPK were detected in 3‐generation MCFs treated with Forskolin(an activating agent of cAMP) ,PD98509(an inhibitor of phospho‐p44/42 MAPK)or Rp‐cAMPS(an inhibitor of PKA).Results The levels of cAMP were increased ,the cell viability decreased ,the expression levels of PKA and CTGF increased and the expression levels of phospho‐p44/42 MAPK declined in MCFs treated with Forskolin. The PKA expression levels were increased while the expression levels of CTGF decreased in MCFs treated with PD 98509.Rp‐cAMPS could inhibit the expression of PKA ,and upregulate the expressions of phospho‐p44/42 MAPK and CTGF.Conclusion Forskolin can inhibit the CTGF expression levels by increasing the intracellular level of cAMP.The involved mechanism is that high levels of cAMP upregulate the PKA expression level ,reduce the phosphorylation level of the downstream target p44/42 MAPK and inhibit the CTGF expression.
What problem does this paper attempt to address?